Regulation of type i plasminogen activator inhibitor in human gingival fibroblasts with cyclosporine A

Oral Diseases

Volumn 16, Issue 4, 2010, Pages 396-401

  Ho, Y C ^a   Lin, H J ^a   Tsai, C H ^a   Chang, Y C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cyclosporine A; Gingival fibroblasts; Gingival overgrowth; Regulatory mechanisms; Type I plasminogen activator inhibitor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; CYCLOSPORIN A; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; CYCLOSPORIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GINGIVA; GINGIVA OVERGROWTH; HUMAN; HUMAN CELL; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; GINGIVAL HYPERTROPHY; METABOLISM;

CELLS, CULTURED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; GINGIVAL HYPERTROPHY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER;

EID: 77950504880     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01653.x     Document Type: Article

References (38)

1. Barazzone C, Belin D, Piguet PF, Vassalli JD, Sappino AP (1996). Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury. J Clin Invest 98 : 2666 2673.
2. Cantin AM, Hubbard RC, Crystal RG (1989). Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 139 : 370 372.
3. Chae HJ, Ha MS, Yun DH et al (2006). Mechanism of cyclosporine-induced overgrowth in gingiva. J Dent Res 85 : 515 519.
4. Chang YC, Yang SF, Lai CC, Liu JY, Hsieh YS (2002). Regulation of matrix metalloproteinases production by cytokines, pharmacological agents, and periodontal pathogens in human periodontal ligament fibroblast cultures. J Periodont Res 37 : 196 203.
5. Chang YC, Chu SC, Yang SF, Hsieh YS, Yang LC, Huang FM (2004). Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1α and Porphyromonas gingivalis in human osteosarcoma cells. J Periodont Res 39 : 168 174.
6. Chang YC, Lai CC, Lin LF, Ni WF, Tsai CH (2005). The upregulation of heme oxygenase-1 expression in human gingival fibroblasts stimulated with nicotine. J Periodont Res 40 : 252 257.
7. Chang YC, Ho YC, Chou LSS, Chou MY, Huang FM (2006). Signal transduction pathways involved in the stimulation of tissue type plasminogen activator by interleukin-1α and Porphyromonas gingivalis in human osteosarcoma cells. J Periodont Res 41 : 374 380.
8. Chang TY, Tsai CH, Chang YC (2009). The upregulation of heat shock protein 47 in human gingival fibroblasts stimulated with cyclosporin A. J Periodont Res. DOI
9. Chen CC, Huang FM, Chen SL, Yang SH, Chang YC (2006). Cytopathologic effects of safrole on human gingival fibroblasts in vitro. J Dent Sci 1 : 126 131.
10. Cotrim P, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD (2003). Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-b1. J Periodontol 74 : 1625 1633.
11. De Vries N, De Flora S (1978). N-acetly-L-cysteine. J Cell Biochem 221 : 713 717.
12. Eitzman DT, McCoy RD, Zheng X et al (1996). Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97 : 232 237.
13. Favata MF, Horiuchi KY, Manos EJ et al (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273 : 18623 18632.
14. Fu E, Nieh S, Wikesjo UME (1997). The effect of plaque retention on cyclosporine A-induced gingival overgrowth in rats. J Periodontol 68 : 92 98.
15. Gillissen A, Novak D (1998). Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Res Med 2 : 609 623.
16. Hassell T, Hefti AF (1991). Drug-induced gingival overgrowth: old problem, new problem. Crit Rev Oral Biol Med 2 : 103 107.
17. Ho YC, Chang YC (2006). Regulation of nicotine-induced cyclooxygenase-2 protein expression in human gingival fibroblasts. Acta Pharmacol Sin 27 : 409 413.
18. Huang FM, Yang SF, Hsieh YS, Liu CM, Yang LC, Chang YC (2004). Examination of the signal transduction pathways involved in matrix metalloproteinases-2 in human pulp cells. Oral Surg Oral Med Oral Pathol 97 : 398 403.
19. James JA, Irwin CR, Linden GJ (1995). The effects of culture environment on the response of human gingival fibroblasts to cyclosporin A. J Periodontol 66 : 339 344.
20. King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis MD, Wiessenfeld D (1993). Gingival hyperplasia in renal allograft recipients receiving cyclosporine-A and calcium antagonists. J Clin Periodontol 20 : 286 293.
21. Lin HJ, Tsai CH, Huang FM, Chang YC (2007). The upregulation of type I plasminogen activator inhibitor in human gingival fibroblasts stimulated with cyclosporin A. J Periodont Res 42 : 39 44.
22. Loskatoff DJ, Sawdey M, Keeton M, Scheiderman J (1993). Regulation of PAI-1 gene expression in vivo. Thromb Haemostasis 70 : 135 137.
23. Mariani G, Calastrini C, Carinci F, Marzola R, Calura G (1993). Ultrastructural features of cyclosporin A-induced gingival hyperplasia. J Periodontol 64 : 1092 1097.
24. Mariotti A, Hassell T, Jacobs D, Manning CJ, Hefti AF (1998). Cyclosporin A and hydroxycyclosporine (M-17) affect the secretory phenotype of human gingival fibroblasts. J Oral Pathol Med 27 : 260 266.
25. Marshall RI, Bartold PM (1999). A clinical review of drug-induced gingival overgrowths. Aust Dent J 44 : 219 232.
26. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML (1992). Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 63 : 548 553.
27. Rostock MH, Fry HR, Turner JE (1986). Severe gingival overgrowth associated with cyclosporine therapy. J Periodontol 57 : 294 299.
28. Seymour RA, Ellis JS, Thomason JM (2000). Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 27 : 217 223.
29. Sprengers ED, Kluft C (1987). Plasminogen activator inhibitors. Blood 69 : 381 387.
30. Takeshita K, Hayashi M, Iino S et al (2004). Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction. Am J Pathol 164 : 449 456.
31. Tsai CH, Chang TY, Chang YC (2009a). Upregulation of lysyl oxidase expression in cyclosporin A-induced gingival overgrowth. J Dent Sci 4 : 13 17.
32. Tsai CH, Yang SF, Huang FM, Chang YC (2009b). The upregulation of cystatin C in human gingival fibroblasts stimulated with cyclosporin A. J Periodont Res 44 : 459 464.
33. Vassalii JD, Sappino AP, Belin D (1991). The plasminogen activator/plasmin system. J Clin Invest 88 : 1067 1072.
34. Wong DYK, Hsiao YL, Poon CK et al (1994). Glutathione concentration in oral cancer tissues. Cancer Lett 81 : 11 16.
35. Yamaguchi M, Naruishi K, Yamada-Naruishi H, Omori K, Nishimura F, Takashiba S (2004). Long-term cyclosporin A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts. J Periodont Res 39 : 320 326.
36. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003). The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39 : 367 372.
37. Yoshida T, Nagata J, Yamane A (2005). Growth factors and proliferation of cultured rat gingival cells in response to cyclosporin A. J Periodont Res 40 : 11 19.
38. Zhang LP, Takahara T, Yata Y et al (1999). Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol 31 : 703 711.